COVID-19, enzima conversora da angiotensina 2 e hidroxicloroquina | Arq. Asma, Alerg. Imunol;4(1): 138-140, jan.mar.2020. ilus | LILACS

Main content 1 Search 2 Footer 3

+A A -A High contrast

COVID-19, enzima conversora da angiotensina 2 e hidroxicloroquina / COVID-19, angiotensin-converting enzyme 2 and hydroxychloroquine

Agondi, Rosana Câmara; Aun, Marcelo Vivolo; Giavina-Bianchi, Pedro.

Affiliation

Agondi, Rosana Câmara; s.af
Aun, Marcelo Vivolo; s.af
Giavina-Bianchi, Pedro; s.af

Arq. Asma, Alerg. Imunol ; 4(1): 138-140, jan.mar.2020. ilus

Article in Pt | LILACS | ID: biblio-1381824

Responsible library: BR2717.9

Subject(s)

Humans; Angiotensins; COVID-19; Hydroxychloroquine; Therapeutics; Chloroquine; Enzymes; SARS-CoV-2

Search on Google

Full text: 1 Index: LILACS Main subject: Angiotensins / COVID-19 / Hydroxychloroquine Limits: Humans Language: Pt Journal: Arq. Asma, Alerg. Imunol Journal subject: Biologia / Cincia Year: 2020 Type: Article

Search on Google

Full text: 1 Index: LILACS Main subject: Angiotensins / COVID-19 / Hydroxychloroquine Limits: Humans Language: Pt Journal: Arq. Asma, Alerg. Imunol Journal subject: Biologia / Cincia Year: 2020 Type: Article